Anti‐TNF‐α therapy alters the gut microbiota in proteoglycan‐induced ankylosing spondylitis in mice

Ankylosing spondylitis is a chronic, progressive disease, and its treatment is relevant to the gut microbiota. Anti‐tumor necrosis factor‐alpha (anti‐TNF‐α) therapy alters the gut microbiota in many diseases, including inflammatory bowel disease. However, little is known about the effect of TNF‐α bl...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Bin, Yang, Lianjun, Cui, Zhifei, Zheng, Junchi, Huang, Jincheng, Zhao, Qinghao, Su, Zhihai, Wang, Min, Zhang, Weicong, Liu, Jinshi, Wang, Tingxuan, Li, Qingchu, Lu, Hai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925169/
https://www.ncbi.nlm.nih.gov/pubmed/31556231
http://dx.doi.org/10.1002/mbo3.927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925169/
https://www.ncbi.nlm.nih.gov/pubmed/31556231
http://dx.doi.org/10.1002/mbo3.927

Ejemplares similares